Zhejiang Yatai Pharmaceutical Co., Ltd.

Zhejiang Yatai Pharmaceutical Co., Ltd. saw a notable stock decline, contrasting with broader market trends. The company faces financial challenges, including a low return on capital and a negative net worth, alongside declining sales and profits over recent quarters. Its market capitalization stands at CNY 2,550 million.

Zhejiang Yatai Pharmaceutical Co., Ltd. saw a notable stock price increase on June 29, 2026, outperforming the China Shanghai Composite. While the company has shown recent gains, its year-to-date performance remains negative, and it faces challenges such as low return on capital and negative net worth in a competitive sector.

Zhejiang Yatai Pharmaceutical Co., Ltd. saw a notable increase in its stock today, contrasting with a decline in the broader market. Despite recent gains, the company faces challenges, including negative net worth and declining sales, while struggling with management efficiency and consecutive quarterly losses.